|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:ALG11-ZFYVE28 (FusionGDB2 ID:4097) |
Fusion Gene Summary for ALG11-ZFYVE28 |
Fusion gene summary |
Fusion gene information | Fusion gene name: ALG11-ZFYVE28 | Fusion gene ID: 4097 | Hgene | Tgene | Gene symbol | ALG11 | ZFYVE28 | Gene ID | 440138 | 57732 |
Gene name | ALG11 alpha-1,2-mannosyltransferase | zinc finger FYVE-type containing 28 | |
Synonyms | CDG1P|GT8 | LST2|LYST2|lst-2 | |
Cytomap | 13q14.3 | 4p16.3 | |
Type of gene | protein-coding | protein-coding | |
Description | GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferaseGDP-Man:Man(3)GlcNAc(2)-PP-dolichol alpha-1,2-mannosyltransferaseasparagine-linked glycosylation 11, alpha-1,2-mannosyltransferase homologasparagine-linked glycosylation protein 11 homologgly | lateral signaling target protein 2 homologhLst2lateral signaling target-2 homologzinc finger FYVE domain-containing protein 28zinc finger, FYVE domain containing 28 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q2TAA5 | . | |
Ensembl transtripts involved in fusion gene | ENST00000523764, ENST00000521508, ENST00000519151, | ENST00000290974, ENST00000511071, ENST00000515312, ENST00000515169, ENST00000509171, ENST00000503000, ENST00000508471, ENST00000505421, | |
Fusion gene scores | * DoF score | 4 X 2 X 3=24 | 9 X 8 X 8=576 |
# samples | 4 | 9 | |
** MAII score | log2(4/24*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(9/576*10)=-2.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ALG11 [Title/Abstract] AND ZFYVE28 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | ALG11(52586598)-ZFYVE28(2275943), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across ALG11 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across ZFYVE28 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUAD | TCGA-55-8513-01A | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
ChimerDB4 | LUAD | TCGA-55-8513-01A | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
Top |
Fusion Gene ORF analysis for ALG11-ZFYVE28 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000523764 | ENST00000290974 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
In-frame | ENST00000523764 | ENST00000511071 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
In-frame | ENST00000523764 | ENST00000515312 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000523764 | ENST00000515169 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000523764 | ENST00000509171 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000523764 | ENST00000503000 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-5UTR | ENST00000523764 | ENST00000508471 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000523764 | ENST00000505421 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
In-frame | ENST00000521508 | ENST00000290974 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
In-frame | ENST00000521508 | ENST00000511071 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
In-frame | ENST00000521508 | ENST00000515312 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000521508 | ENST00000515169 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000521508 | ENST00000509171 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000521508 | ENST00000503000 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-5UTR | ENST00000521508 | ENST00000508471 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
5CDS-intron | ENST00000521508 | ENST00000505421 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-3CDS | ENST00000519151 | ENST00000290974 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-3CDS | ENST00000519151 | ENST00000511071 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-3CDS | ENST00000519151 | ENST00000515312 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-intron | ENST00000519151 | ENST00000515169 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-intron | ENST00000519151 | ENST00000509171 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-intron | ENST00000519151 | ENST00000503000 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-5UTR | ENST00000519151 | ENST00000508471 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
intron-intron | ENST00000519151 | ENST00000505421 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000523764 | ALG11 | chr13 | 52586598 | + | ENST00000290974 | ZFYVE28 | chr4 | 2275943 | - | 1805 | 65 | 21 | 677 | 218 |
ENST00000523764 | ALG11 | chr13 | 52586598 | + | ENST00000511071 | ZFYVE28 | chr4 | 2275943 | - | 1064 | 65 | 21 | 677 | 218 |
ENST00000523764 | ALG11 | chr13 | 52586598 | + | ENST00000515312 | ZFYVE28 | chr4 | 2275943 | - | 908 | 65 | 21 | 677 | 218 |
ENST00000521508 | ALG11 | chr13 | 52586598 | + | ENST00000290974 | ZFYVE28 | chr4 | 2275943 | - | 1789 | 49 | 5 | 661 | 218 |
ENST00000521508 | ALG11 | chr13 | 52586598 | + | ENST00000511071 | ZFYVE28 | chr4 | 2275943 | - | 1048 | 49 | 5 | 661 | 218 |
ENST00000521508 | ALG11 | chr13 | 52586598 | + | ENST00000515312 | ZFYVE28 | chr4 | 2275943 | - | 892 | 49 | 5 | 661 | 218 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000523764 | ENST00000290974 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.028359175 | 0.9716409 |
ENST00000523764 | ENST00000511071 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.013347009 | 0.98665303 |
ENST00000523764 | ENST00000515312 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.007395029 | 0.992605 |
ENST00000521508 | ENST00000290974 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.033965584 | 0.9660344 |
ENST00000521508 | ENST00000511071 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.015469201 | 0.9845308 |
ENST00000521508 | ENST00000515312 | ALG11 | chr13 | 52586598 | + | ZFYVE28 | chr4 | 2275943 | - | 0.008668689 | 0.99133134 |
Top |
Fusion Genomic Features for ALG11-ZFYVE28 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ALG11-ZFYVE28 |
Go to FGviewer for the breakpoints of chr13:52586598-chr4:2275943 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
ALG11 | . |
FUNCTION: Mannosyltransferase involved in the last steps of the synthesis of Man5GlcNAc(2)-PP-dolichol core oligosaccharide on the cytoplasmic face of the endoplasmic reticulum. Catalyzes the addition of the 4th and 5th mannose residues to the dolichol-linked oligosaccharide chain. {ECO:0000269|PubMed:20080937}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000290974 | 7 | 13 | 817_879 | 683.6666666666666 | 888.0 | Zinc finger | FYVE-type | |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000503000 | 0 | 7 | 817_879 | 0 | 288.0 | Zinc finger | FYVE-type | |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000509171 | 0 | 5 | 817_879 | 0 | 173.0 | Zinc finger | FYVE-type | |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000511071 | 6 | 12 | 817_879 | 653.6666666666666 | 858.0 | Zinc finger | FYVE-type | |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000515169 | 0 | 7 | 817_879 | 0 | 164.0 | Zinc finger | FYVE-type | |
Tgene | ZFYVE28 | chr13:52586598 | chr4:2275943 | ENST00000515312 | 7 | 13 | 817_879 | 613.6666666666666 | 818.0 | Zinc finger | FYVE-type |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | ALG11 | chr13:52586598 | chr4:2275943 | ENST00000521508 | + | 1 | 4 | 20_40 | 14.666666666666666 | 493.0 | Transmembrane | Helical |
Hgene | ALG11 | chr13:52586598 | chr4:2275943 | ENST00000521508 | + | 1 | 4 | 234_254 | 14.666666666666666 | 493.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for ALG11-ZFYVE28 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000523764_ENST00000290974_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=1805nt_BP=65nt GAGTTCGGGGGTCGGCGGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCC TCAGACAAGATGGGGCCAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGC AGCCACGACCTCATCCACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATT CTTAAAACACTGTTTGAGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCG GCCTTGGAGGACTGTGCACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCG GAGTGGGTGCCAGACGAGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGT GGGAAGATCTTCTGCTCGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGC TACATGTTCCATGTCACGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACC CCCAGGAAGGTGGGGCCACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGC ATCCAGAGCCTCTGTCCTGCCCACGCTAGCCTCCCTGCAGGGACCCCGGGCCGGCTGCAGGGGCCAACAAGAGGTCAGCTTTGCCCAGCA GGGGACCCGGAGGAGCCTGGTGGCTGCCTCAGGGCAGGGTGCCTGGCGGAGAAGGCCTGGGCCCTCCCACTGGTCCCTCGGAGATCTGCT GGGGCTATGGGAATCGGGGCGGGTGATGGAGGTGGACAAGAGTGGGGCCACTCTGCGCCTCTGCTGTTGCGGTGAATCTGGAAGCCGGAG CAAGGGCCACTCCACAGGCTCTTTGGCACAGCAGGGCTCCCTATGTGCCTCCCAAACGTCAAATGCAGGCTACCCATTCTCCCCATCAGC TGCCCACCTCGTTCCCCAGCCCTCACCCCTCACCCCTCACCATCCTTCCTCAGGACTTGGCTAAACAACATGCATCTCATTTCTTCTTGG AGTGGGGAGATGCGGGAAGCTGACCCAGTGGTCCTCTAGGCAGGCAGGGTGCTCCTGGTGTCTGCCCACCACTGTCCCCTTGCTGATGGC ATGGGGGTCCGACCAGGCACTGACACCGCAGGCAGAGGTTGCTCGGGGCCTTGGGTCGGGTTTACCAATCAGCCAGGACGCCCGGGGCCA CCAGCTCAGCTACCACTTCCCCTTCCCTCTGCACCCTCTGGAACCCTGGCCCAATTCCTCAGACCCCAGAGTGGCCTGGGACCCAAGCTG CCGCAGCTGAGTGGCCCCAGCGGACACCTCCTCAGGCTTAAATCTCAGGCTTCACATTGCAATGACGATTGCAGTTTTATTTTTGGAGAT GACACACCTACTGCTTCTTTTCTAGGATAAATCTAATTACTGTTTACTGGTGGAGTACATATGCATAGAAACGGCTTCTGTCGGGGGGAG AGTATATAATGGAGGAAATATTATGTATTGAGATTATATTTATTTTCTAAATGCTGTAATTTGAAGCCATTTCCATAAATCTATTTAAGG >In-frame_ENST00000523764_ENST00000290974_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=21_stop in transcript=677 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- >In-frame_ENST00000523764_ENST00000511071_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=1064nt_BP=65nt GAGTTCGGGGGTCGGCGGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCC TCAGACAAGATGGGGCCAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGC AGCCACGACCTCATCCACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATT CTTAAAACACTGTTTGAGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCG GCCTTGGAGGACTGTGCACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCG GAGTGGGTGCCAGACGAGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGT GGGAAGATCTTCTGCTCGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGC TACATGTTCCATGTCACGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACC CCCAGGAAGGTGGGGCCACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGC ATCCAGAGCCTCTGTCCTGCCCACGCTAGCCTCCCTGCAGGGACCCCGGGCCGGCTGCAGGGGCCAACAAGAGGTCAGCTTTGCCCAGCA GGGGACCCGGAGGAGCCTGGTGGCTGCCTCAGGGCAGGGTGCCTGGCGGAGAAGGCCTGGGCCCTCCCACTGGTCCCTCGGAGATCTGCT >In-frame_ENST00000523764_ENST00000511071_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=21_stop in transcript=677 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- >In-frame_ENST00000523764_ENST00000515312_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=908nt_BP=65nt GAGTTCGGGGGTCGGCGGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCC TCAGACAAGATGGGGCCAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGC AGCCACGACCTCATCCACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATT CTTAAAACACTGTTTGAGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCG GCCTTGGAGGACTGTGCACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCG GAGTGGGTGCCAGACGAGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGT GGGAAGATCTTCTGCTCGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGC TACATGTTCCATGTCACGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACC CCCAGGAAGGTGGGGCCACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGC ATCCAGAGCCTCTGTCCTGCCCACGCTAGCCTCCCTGCAGGGACCCCGGGCCGGCTGCAGGGGCCAACAAGAGGTCAGCTTTGCCCAGCA >In-frame_ENST00000523764_ENST00000515312_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=21_stop in transcript=677 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- >In-frame_ENST00000521508_ENST00000290974_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=1789nt_BP=49nt GGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCCTCAGACAAGATGGGGC CAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGCAGCCACGACCTCATCC ACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATTCTTAAAACACTGTTTG AGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCGGCCTTGGAGGACTGTG CACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCGGAGTGGGTGCCAGACG AGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGTGGGAAGATCTTCTGCT CGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGCTACATGTTCCATGTCA CGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACCCCCAGGAAGGTGGGGC CACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGCATCCAGAGCCTCTGTC CTGCCCACGCTAGCCTCCCTGCAGGGACCCCGGGCCGGCTGCAGGGGCCAACAAGAGGTCAGCTTTGCCCAGCAGGGGACCCGGAGGAGC CTGGTGGCTGCCTCAGGGCAGGGTGCCTGGCGGAGAAGGCCTGGGCCCTCCCACTGGTCCCTCGGAGATCTGCTGGGGCTATGGGAATCG GGGCGGGTGATGGAGGTGGACAAGAGTGGGGCCACTCTGCGCCTCTGCTGTTGCGGTGAATCTGGAAGCCGGAGCAAGGGCCACTCCACA GGCTCTTTGGCACAGCAGGGCTCCCTATGTGCCTCCCAAACGTCAAATGCAGGCTACCCATTCTCCCCATCAGCTGCCCACCTCGTTCCC CAGCCCTCACCCCTCACCCCTCACCATCCTTCCTCAGGACTTGGCTAAACAACATGCATCTCATTTCTTCTTGGAGTGGGGAGATGCGGG AAGCTGACCCAGTGGTCCTCTAGGCAGGCAGGGTGCTCCTGGTGTCTGCCCACCACTGTCCCCTTGCTGATGGCATGGGGGTCCGACCAG GCACTGACACCGCAGGCAGAGGTTGCTCGGGGCCTTGGGTCGGGTTTACCAATCAGCCAGGACGCCCGGGGCCACCAGCTCAGCTACCAC TTCCCCTTCCCTCTGCACCCTCTGGAACCCTGGCCCAATTCCTCAGACCCCAGAGTGGCCTGGGACCCAAGCTGCCGCAGCTGAGTGGCC CCAGCGGACACCTCCTCAGGCTTAAATCTCAGGCTTCACATTGCAATGACGATTGCAGTTTTATTTTTGGAGATGACACACCTACTGCTT CTTTTCTAGGATAAATCTAATTACTGTTTACTGGTGGAGTACATATGCATAGAAACGGCTTCTGTCGGGGGGAGAGTATATAATGGAGGA >In-frame_ENST00000521508_ENST00000290974_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=5_stop in transcript=661 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- >In-frame_ENST00000521508_ENST00000511071_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=1048nt_BP=49nt GGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCCTCAGACAAGATGGGGC CAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGCAGCCACGACCTCATCC ACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATTCTTAAAACACTGTTTG AGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCGGCCTTGGAGGACTGTG CACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCGGAGTGGGTGCCAGACG AGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGTGGGAAGATCTTCTGCT CGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGCTACATGTTCCATGTCA CGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACCCCCAGGAAGGTGGGGC CACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGCATCCAGAGCCTCTGTC CTGCCCACGCTAGCCTCCCTGCAGGGACCCCGGGCCGGCTGCAGGGGCCAACAAGAGGTCAGCTTTGCCCAGCAGGGGACCCGGAGGAGC CTGGTGGCTGCCTCAGGGCAGGGTGCCTGGCGGAGAAGGCCTGGGCCCTCCCACTGGTCCCTCGGAGATCTGCTGGGGCTATGGGAATCG >In-frame_ENST00000521508_ENST00000511071_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=5_stop in transcript=661 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- >In-frame_ENST00000521508_ENST00000515312_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(transcript)=892nt_BP=49nt GGAAGATGGCGGCCGGCGAAAGGAGCTGGTGCCTGTGCAAGTTGTTGAGCAGCTCCACAGCTGGGTCCTGCTCCTCAGACAAGATGGGGC CAGAGGCGGCCCCAGCAGCCACGCATGCTGCCCCACAGGCCACAAGAGAGAAGATCCGGTCCAGGTTCCACGGCAGCCACGACCTCATCC ACCGCCTGTTCGTCTGCATTTCAGGTGTGGCTGACCAGCTGCAGACGAACTATGCCAGTGACCTGAGAAGTATTCTTAAAACACTGTTTG AGGTCATGGCCACCAAGCCTGAAACAGACGACAAGGAAAAGTTAAGGAAGGTCACCCAGACTCTGCGGAGTGCGGCCTTGGAGGACTGTG CACTGTGCCAGGAGACCCTGTCATCCTCTGAACTGGCAGCCAAGACCCGCGATGGGGACTTTGAAGACCCCCCGGAGTGGGTGCCAGACG AGGCCTGTGGCTTCTGCACGGCGTGCAAAGCACCCTTCACCGTCATCCGCCGGAAGCACCACTGCCGCAGCTGTGGGAAGATCTTCTGCT CGCGCTGCTCCTCGCACTCAGCACCGCTGCCCCGCTACGGGCAGGTGAAGCCGGTCCGAGTGTGCACCCACTGCTACATGTTCCATGTCA CGCCCTTCTACAGCGACAAGGCCGGCCTGTGACGTGGTGCCAGGGGCAGCCCCAACCCACCCGGGCCAGGAACCCCCAGGAAGGTGGGGC CACGCTGCAGGCAGGTCTCACTGCGTCTCATGAGGCCGCTGCCGCTGCTGCAGGGGCACCCAGACCTCCAGAGCATCCAGAGCCTCTGTC >In-frame_ENST00000521508_ENST00000515312_TCGA-55-8513-01A_ALG11_chr13_52586598_+_ZFYVE28_chr4_2275943_length(amino acids)=218AA_start in transcript=5_stop in transcript=661 MAAGERSWCLCKLLSSSTAGSCSSDKMGPEAAPAATHAAPQATREKIRSRFHGSHDLIHRLFVCISGVADQLQTNYASDLRSILKTLFEV MATKPETDDKEKLRKVTQTLRSAALEDCALCQETLSSSELAAKTRDGDFEDPPEWVPDEACGFCTACKAPFTVIRRKHHCRSCGKIFCSR -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ALG11-ZFYVE28 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ALG11-ZFYVE28 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ALG11-ZFYVE28 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ALG11 | C3150913 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |